drugset / Trial / NCT03895385
A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of the study is to evaluate whether administration of bimekizumab has an effect on the expected production of antibody titers to the influenza vaccine.
Timeline
- Start
- 2019-04-02
- Primary completion
- 2019-10-04
- Completion
- 2019-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimekizumab | Monoclonal antibody | — | — |
Indications
No indication recorded.